Alkem Lab

44
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,500.00
-183 (-3.22%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 38.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Alkem Lab Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
2,870.00
2,527.00
2,023.00
1,304.00
1,844.00
1,842.00
Adjustment
136.00
103.00
383.00
324.00
208.00
164.00
Changes In working Capital
-415.00
-213.00
-51.00
326.00
-544.00
-341.00
Cash Flow after changes in Working Capital
2,592.00
2,416.00
2,355.00
1,955.00
1,507.00
1,665.00
Cash Flow from Operating Activities
1,963.00
1,912.00
1,948.00
1,682.00
1,111.00
1,264.00
Cash Flow from Investing Activities
-1,681.00
-1,288.00
-1,010.00
119.00
-1,432.00
-994.00
Cash Flow from Financing Activities
-503.00
-810.00
-1,145.00
-1,760.00
379.00
-271.00
Net Cash Inflow / Outflow
-222.00
-186.00
-207.00
41.00
57.00
-1.00
Opening Cash & Cash Equivalents
-120.00
66.00
273.00
232.00
174.00
175.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
-342.00
-120.00
66.00
273.00
232.00
174.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Alkem Lab
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
2870.89
1429.4
1,441.00
100.85%
Adjustment
136.33
2168.4
-2,032.00
-93.71%
Changes In working Capital
-415.17
923
-1,338.00
-144.98%
Cash Flow after changes in Working Capital
2592.05
4520.8
-1,928.00
-42.66%
Cash Flow from Operating Activities
1963.03
4061.2
-2,098.00
-51.66%
Cash Flow from Investing Activities
-1681.67
-202.9
-1,479.00
-728.82%
Cash Flow from Financing Activities
-503.4
-1854
1,351.00
72.85%
Net Cash Inflow / Outflow
-222.04
2004.3
-2,226.00
-111.08%
Opening Cash & Cash Equivalents
-120.09
919.5
-1,039.00
-113.06%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
-342.13
2923.8
-3,265.00
-111.70%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 2.62% vs -1.81% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,963.03
1,912.84
2.62%